Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/Compare

LCID vs RIVN

LCID and RIVN side by side — valuation & fundamentals (public data).

Key statistics

LCID vs RIVN key statistics
MetricLCIDLucid Group, Inc.RIVNRivian Automotive, Inc. / DE
Market cap$1.63B$21.17B
P/B—3.59
P/S1.2x3.9x
Revenue—$5.88B(TTM)
Revenue growth (YoY)67.6%8.4%
Net income—-$3.23B(TTM)
Earnings growth (YoY)0.6%23.2%
EPS, diluted—$-2.59(TTM)
EBIT margin-258.7%-66.5%
ROE—-61.8%
ROIC-327.5%-53.1%
Piotroski F2/9—
1y total return-79.2%+14.2%

Figures from SEC filings · for reference only · not investment advice

Growth of $10,000: LCID vs RIVN

$10.0K$101$1.5K2021-11-102026-09-15
MetricLCIDRIVN
End value$101$1.5K
Total return-99.0%-84.6%
CAGR-61.3%-32.0%
Volatility83.2%77.1%
Sharpe-0.79-0.17
Sortino-1.18-0.25
Max drawdown-99.3%-95.1%

Based on 1215 common trading days, 2021-11-10 → 2026-09-15 · risk-free 4.11% (current short-Treasury, held constant)

A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.

Related comparisons

RIVN vs LCIDRIVN vs TSLALCID vs TSLAF vs LCIDF vs RIVNAAPL vs MSFT

Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)